Compare Wegovy vs Mounjaro from a Trusted UK Pharmacy
GPhC-Registered Pharmacy: Your Wegovy vs Mounjaro Weight Loss Comparison
When comparing Wegovy vs Mounjaro for weight loss, choosing a genuinely regulated UK pharmacy makes all the difference to your treatment safety and success. EverydayMeds operates as a fully licensed pharmacy under GPhC registration #9012878, which you can independently verify on pharmacyregulation.org alongside our registered Leicester address. Unlike unregulated online suppliers, every aspect of our service meets strict pharmaceutical standards, from our MHRA-compliant supply chain to our licensed prescriber oversight of every consultation.
Both Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescription-only medicines that require proper clinical assessment before dispensing. Our regulatory framework ensures that whether you're considering Wegovy's single GLP-1 approach or Mounjaro's dual GIP+GLP-1 mechanism, you'll receive genuine medication with full traceability and professional support throughout your weight management journey.
Wegovy vs Mounjaro Weight Loss: Pricing and Value Comparison
Understanding the cost structure for Wegovy vs Mounjaro weight loss treatments helps you plan your investment in your health journey. Wegovy follows a structured dose escalation: 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices.
Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, offering 12 weeks of treatment progression in one order. The Ultimate Stability Trio provides three months of 2.4mg maintenance doses for £649.99, ensuring consistent supply without monthly reordering. Both Wegovy and Mounjaro are available through our regulated dispensing process with identical clinical assessment requirements.
Clinical Evidence: Wegovy vs Mounjaro for Weight Loss Effectiveness
Clinical trial data provides important context when comparing Wegovy vs Mounjaro for weight loss, though direct head-to-head studies remain limited. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks in STEP 1, with sustained results of 15.2% at 2 years in STEP 5 (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events with semaglutide treatment.
Mounjaro's SURMOUNT trials showed its dual GIP+GLP-1 mechanism may support weight management through different pathways than Wegovy's single GLP-1 approach. However, comparing trial percentages directly isn't scientifically valid due to different study populations, endpoints, and methodologies. Both treatments require ongoing commitment, as weight regain typically occurs when treatment discontinues.
How Wegovy Works: GLP-1 Mechanism for Weight Loss
Understanding how Wegovy works helps inform your Wegovy vs Mounjaro weight loss decision-making process. Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines when you eat. This mechanism may help reduce appetite by acting on brain centres that control hunger and satiety. Patients often report feeling fuller after smaller meals and experiencing fewer food cravings throughout their treatment. The once-weekly injection provides sustained hormone-like activity, supporting consistent appetite regulation. Wegovy must be used alongside a reduced-calorie diet and increased physical activity to achieve optimal results.
Ordering Process: Wegovy vs Mounjaro Weight Loss Assessment
Our streamlined ordering process ensures proper clinical oversight whether you're considering Wegovy vs Mounjaro for weight loss management. The journey begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any contraindications. Licensed UK prescribers review every consultation within 3 working days (or 24 hours with express service), ensuring treatment suitability before dispensing any prescription-only medicine. Once approved, your medication ships via next-day cold-chain delivery, maintaining the critical 2-8°C temperature requirements from our pharmacy to your door. Our clinical team remains available for ongoing support throughout your treatment journey, monitoring progress and addressing any concerns that arise.
Storage and Practical Considerations: Wegovy vs Mounjaro Weight Loss
Practical storage differences may influence your Wegovy vs Mounjaro weight loss treatment choice, particularly for travel or lifestyle considerations. Wegovy requires refrigeration at 2-8°C but offers superior room temperature stability, remaining effective for up to 6 weeks below 30°C once removed from the fridge. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more convenient for extended travel or lifestyle flexibility. The FlexTouch pen design provides straightforward once-weekly administration with clear dose confirmation. Dose escalation follows a mandatory schedule over 16 weeks, gradually increasing from 0.25mg to the 2.4mg maintenance dose to minimise potential side effects.
GPhC Pharmacy Regulation: Ensuring Safe Wegovy vs Mounjaro Weight Loss Treatment
The regulatory oversight provided by GPhC-registered pharmacies becomes particularly crucial when comparing Wegovy vs Mounjaro for weight loss, given both are prescription-only medicines requiring professional supervision. Our pharmacy registration #9012878 demonstrates compliance with strict standards covering everything from premises inspections to staff qualifications and clinical governance. This regulatory framework ensures that whether you choose Wegovy's established GLP-1 approach or are considering Mounjaro's newer dual-agonist mechanism, you receive genuine medication with full provenance tracking.
Unregulated suppliers cannot legally dispense these prescription-only medicines, making GPhC registration your essential safeguard for treatment safety and efficacy. Our Leicester-based pharmacy undergoes regular inspections, maintains professional indemnity insurance, and operates under strict clinical protocols that protect patients throughout their weight management journey.
Making Your Decision: Wegovy vs Mounjaro Weight Loss Consultation
Ultimately, the choice between Wegovy vs Mounjaro for weight loss should be made in consultation with qualified healthcare professionals who can assess your individual circumstances, medical history, and treatment goals. Both treatments are available from EverydayMeds with identical clinical assessment standards and ongoing prescriber support. Our licensed practitioners can help determine which mechanism—Wegovy's focused GLP-1 approach or Mounjaro's dual GIP+GLP-1 action—may be most suitable for your needs. New customers can begin their clinical assessment today using discount code FIRST40, while returning customers benefit from streamlined consultations with code DOSE25. Visit https://everydaymeds.co.uk/collections/wegovy to start your professionally supervised weight management journey with the confidence that comes from choosing a fully regulated UK pharmacy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
